ATAGI statement on the administration of influenza vaccines in 2021
The ATAGI 2021 Influenza Statement on the administration of seasonal influenza vaccines is now available.
![](/sites/default/files/styles/limit_height/public/2021-03/injection%20with%20gloved%20hands.jpg?itok=IVd4oMpe)
Overview of key points and updates for 2021:
-
Annual influenza vaccination is recommended for all people ≥6 months of age. It is the most important measure to prevent influenza and its complications.
-
Influenza vaccinations must be recorded on the Australian Immunisation Register (AIR).
-
Co-administration of influenza vaccine on the same day as a COVID-19 vaccine is not recommended.
-
Administration of an influenza vaccine and a COVID-19 vaccine should be a minimum of 14 days apart.
-
A new cell-based influenza vaccine (Flucelvax Quad®) is available but not funded under the National Immunisation Program (NIP).
-
For adults aged ≥65 years, the adjuvanted influenza vaccine, Fluad® Quad, is preferentially recommended over standard influenza vaccine.